Differential diagnosis of cervical intraepithelial neoplasia of varying severity via quantitative assessment of anti-oncogenic microRNA expression
- Authors: Karnaukhov V.N.1, Faizullin L.Z.1, Nazarova N.M.1, Mzarelua G.M.1, Bairamova G.R.1, Chernova V.F.1, Faizullin A.L.2, Kozachenko A.V.1, Trofimov D.Y.1, Prilepskaya V.N.1, Sukhikh G.T.1
-
Affiliations:
- Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
- I.M. Sechenov First Moscow State Medical University
- Issue: No 3 (2017)
- Pages: 82-88
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247953
- DOI: https://doi.org/10.18565/aig.2017.3.82-8
- ID: 247953
Cite item
Abstract
Full Text
About the authors
Vitaliy Nikolaevich Karnaukhov
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: v_kamauhov@oparina4.ru
Junior Researcher, Laboratory of Molecular Genetic Methods
Leonid Zakievich Faizullin
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: l_faizullin@oparina4.ru
Cand. Sc. (Biology), Leading Researcher, Laboratory of Molecular Genetic Methods
Niso Mirzoevna Nazarova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: grab2@yandex.ru
MD, PhD, Senior Researcher
Guranda Merabovna Mzarelua
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: mzareluag@mail.ru
PhD student
Guldana Raufovna Bairamova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: g_bairamova@oparina4.ru
doctor of medical sciences, head of the clinical work of the scientific and polyclinic department
Victoria Fedorovna Chernova
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of RussiaPhD student
Alexey Leonidovich Faizullin
I.M. Sechenov First Moscow State Medical University
Email: a.iiepcuk@gmail.com
a student of the 6th year; Center for Innovative Educational Programs
Andrey Vladimirovich Kozachenko
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: a_kozachenko@oparina4.ru
leading research assistant of the gynecological department
Dmitriy Yurievich Trofimov
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: d_trofimov@oparina4.ru
Doctor of Biological Sciences, Head of the Laboratory of Molecular Genetic Methods
Vera Nikolaevna Prilepskaya
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: VPrilepskaya@mail.ru
MD, PhD, Professor, Deputy Director for Science
Gennady Tikhonovich Sukhikh
Research Center of Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia
Email: g_sukhikh@oparina4.ru
Doctor of Medical Sciences, Academician of the Russian Academy of Sciences, Director
References
- Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61(2): 69-90.
- Давыдов М.И., Аксель Е.М., ред. Статистика злокачественных новообразований в России и странах СНГ в 2012 г. М.: Издательская группа РОНЦ; 2014: 47. [Davydov M.I., Aksel E.M., ed. Statistics of malignant neoplasms in Russia and the CIS countries in 2012. Moscow: Publishing group RONTS; 2014: 47. (in Russian)]
- Seoud M., Tjalma W.A., Ronsse V. Cervical adenocarcinoma: moving towards better prevention. Vaccine. 2011; 29(49): 9148-58.
- Knoff J., Yang B., Hung C.F., Wu T.C. Cervical cancer: development of targeted therapies beyond molecular pathogenesis. Curr. Obstet. Gynecol. Rep. 2014; 3(1): 18-32.
- Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63(6): 1129-36.
- Roman A., Munger K. The papillomavirus E7 proteins. Virology. 2013; 445(1-2): 138-68.
- Stahlhut C., Slack F.J. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome Med. 2013; 5(12): 111.
- Frixa T., Donzelli S., Blandino G. Oncogenic microRNAs: key players in malignant transformation. Cancers (Basel). 2015; 7(4): 2466-85.
- Wang F., Li B., Xie X. The roles and clinical significance of microRNAs in cervical cancer. Histol. Histopathol. 2016; 31(2): 131-9.
- Galamb Á., Benczik M., Zinner B., Vigh E., Baghy K., Jeney C. et al. Dysregulation of microRNA expression in human cervical preneoplastic and neoplastic lesions. Pathol. Oncol. Res. 2015; 21(3): 503-8.
- Файзуллин Л.З., Карнаухов В.Н., Мзарелуа Г.М., Чернова В.Ф. Экспрессия микроРНК при цервикальной интраэпителиальной неоплазии и раке шейки матки. Акушерство и гинекология. 2015; 9: 27-32. [Faizullin L.Z., Karnaukhov V.N., Mzarelua G.M., Chernova V.F. MicroRNA expression in cervical intraepithelial neoplasia and cancer of the cervix uteri. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2015; (9): 27-32. (in Russian)]
- Nassirpour R., Mehta P.P., Yin M.J. miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3. PLoS One. 2013; 8: e79655.
- Ergün S., Ulasli M., Igci Y.Z., Igci M., Kirkbes S., Borazan E. et al. The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer. Mol. Biol. Rep. 2015; 42(2): 497-505.
- Kent O.A., McCall M.N., Cornish T.C., Halushka M.K. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res. 2014; 42(12): 7528-38.
- Akao Y., Nakagawa Y., Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol. Rep. 2006; 16(4): 845-50.
- Pekow J., Meckel K., Dougherty U., Butun E., Mustafi R., Lim J. et al. Tumor suppressors miRNA-143 and miR-145 and predicted target proteins API5, ERK5, KRAS, and IRS-1 are differentially expressed in proximal and distal colon. Am. J. Physiol. Gastrointest. Liver Physiol. 2015; 308(3): G179-87.
- Sachdeva M., Mo Y.Y. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010; 70(1): 378-87.
- Filipowicz W., Grosshans H. The liver-specific microRNA miR-122: biology and therapeutic potential. Prog. Drug Res. 2011; 67: 221-38.